tyrosine-protein phosphatase non-receptor type 20 isoform 9 [Homo sapiens]
List of domain hits
Name | Accession | Description | Interval | E-value | ||
PTPc super family | cl33376 | Protein tyrosine phosphatase, catalytic domain; |
78-116 | 1.98e-05 | ||
Protein tyrosine phosphatase, catalytic domain; The actual alignment was detected with superfamily member smart00194: Pssm-ID: 214550 [Multi-domain] Cd Length: 259 Bit Score: 42.65 E-value: 1.98e-05
|
||||||
Name | Accession | Description | Interval | E-value | ||
PTPc | smart00194 | Protein tyrosine phosphatase, catalytic domain; |
78-116 | 1.98e-05 | ||
Protein tyrosine phosphatase, catalytic domain; Pssm-ID: 214550 [Multi-domain] Cd Length: 259 Bit Score: 42.65 E-value: 1.98e-05
|
||||||
PTPc-N9 | cd14543 | catalytic domain of tyrosine-protein phosphatase non-receptor type 9; Tyrosine-protein ... |
78-116 | 1.40e-04 | ||
catalytic domain of tyrosine-protein phosphatase non-receptor type 9; Tyrosine-protein phosphatase non-receptor type 9 (PTPN9), also called protein-tyrosine phosphatase MEG2, belongs to the family of classical tyrosine-specific protein tyrosine phosphatases (PTPs). PTPs (EC 3.1.3.48) catalyze the dephosphorylation of phosphotyrosine peptides. PTPN9 plays an important role in promoting intracellular secretary vesicle fusion in hematopoietic cells and promotes the dephosphorylation of ErbB2 and EGFR in breast cancer cells, leading to impaired activation of STAT5 and STAT3. It also directly dephosphorylates STAT3 at the Tyr705 residue, resulting in its inactivation. PTPN9 has been found to be dysregulated in various human cancers, including breast, colorectal, and gastric cancer. Pssm-ID: 350391 [Multi-domain] Cd Length: 271 Bit Score: 40.43 E-value: 1.40e-04
|
||||||
Name | Accession | Description | Interval | E-value | ||
PTPc | smart00194 | Protein tyrosine phosphatase, catalytic domain; |
78-116 | 1.98e-05 | ||
Protein tyrosine phosphatase, catalytic domain; Pssm-ID: 214550 [Multi-domain] Cd Length: 259 Bit Score: 42.65 E-value: 1.98e-05
|
||||||
PTPc-N9 | cd14543 | catalytic domain of tyrosine-protein phosphatase non-receptor type 9; Tyrosine-protein ... |
78-116 | 1.40e-04 | ||
catalytic domain of tyrosine-protein phosphatase non-receptor type 9; Tyrosine-protein phosphatase non-receptor type 9 (PTPN9), also called protein-tyrosine phosphatase MEG2, belongs to the family of classical tyrosine-specific protein tyrosine phosphatases (PTPs). PTPs (EC 3.1.3.48) catalyze the dephosphorylation of phosphotyrosine peptides. PTPN9 plays an important role in promoting intracellular secretary vesicle fusion in hematopoietic cells and promotes the dephosphorylation of ErbB2 and EGFR in breast cancer cells, leading to impaired activation of STAT5 and STAT3. It also directly dephosphorylates STAT3 at the Tyr705 residue, resulting in its inactivation. PTPN9 has been found to be dysregulated in various human cancers, including breast, colorectal, and gastric cancer. Pssm-ID: 350391 [Multi-domain] Cd Length: 271 Bit Score: 40.43 E-value: 1.40e-04
|
||||||
PTPc-N12 | cd14604 | catalytic domain of tyrosine-protein phosphatase non-receptor type 12; Tyrosine-protein ... |
95-116 | 2.16e-03 | ||
catalytic domain of tyrosine-protein phosphatase non-receptor type 12; Tyrosine-protein phosphatase non-receptor type 12 (PTPN12), also called PTP-PEST or protein-tyrosine phosphatase G1 (PTPG1), belongs to the family of classical tyrosine-specific protein tyrosine phosphatases (PTPs). PTPs (EC 3.1.3.48) catalyze the dephosphorylation of phosphotyrosine peptides. PTPN12 is characterized as a tumor suppressor and a pivotal regulator of EGFR/HER2 signaling. It regulates various physiological processes, including cell migration, immune response, and neuronal activity, by dephosphorylating multiple substrates including HER2, FAK, PYK2, PSTPIP, WASP, p130Cas, paxillin, Shc, catenin, c-Abl, ArgBP2, p190RhoGAP, RhoGDI, cell adhesion kinase beta, and Rho GTPase. Pssm-ID: 350452 [Multi-domain] Cd Length: 297 Bit Score: 36.83 E-value: 2.16e-03
|
||||||
PTPc-N14 | cd14599 | catalytic domain of tyrosine-protein phosphatase non-receptor type 14; Tyrosine-protein ... |
67-115 | 2.43e-03 | ||
catalytic domain of tyrosine-protein phosphatase non-receptor type 14; Tyrosine-protein phosphatase non-receptor type 14 (PTPN14), also called protein-tyrosine phosphatase pez, belongs to the family of classical tyrosine-specific protein tyrosine phosphatases (PTPs). PTPs (EC 3.1.3.48) catalyze the dephosphorylation of phosphotyrosine peptides. PTPN14 is a potential tumor suppressor and plays a regulatory role in the Hippo and Wnt/beta-catenin signaling pathways. It contains an N-terminal FERM domain and a C-terminal catalytic PTP domain, separated by a long intervening sequence. Pssm-ID: 350447 [Multi-domain] Cd Length: 287 Bit Score: 36.90 E-value: 2.43e-03
|
||||||
PTPc-N6 | cd14606 | catalytic domain of tyrosine-protein phosphatase non-receptor type 6; Tyrosine-protein ... |
97-116 | 2.95e-03 | ||
catalytic domain of tyrosine-protein phosphatase non-receptor type 6; Tyrosine-protein phosphatase non-receptor type 6 (PTPN6), also called SH2 domain-containing protein-tyrosine phosphatase 1 (SHP1 or SHP-1), belongs to the family of classical tyrosine-specific protein tyrosine phosphatases (PTPs). PTPs (EC 3.1.3.48) catalyze the dephosphorylation of phosphotyrosine peptides. PTPN6 expression is restricted mainly to hematopoietic and epithelial cells. It is an important regulator of hematopoietic cells, downregulating pathways that promote cell growth, survival, adhesion, and activation. It regulates glucose homeostasis by modulating insulin signalling in the liver and muscle, and it also negatively regulates bone resorption, affecting both the formation and the function of osteoclasts. PTPN6 contains two tandem SH2 domains, a catalytic PTP domain, and a C-terminal tail with regulatory properties. Pssm-ID: 350454 [Multi-domain] Cd Length: 266 Bit Score: 36.40 E-value: 2.95e-03
|
||||||
PTPc-N11_6 | cd14544 | catalytic domain of tyrosine-protein phosphatase non-receptor type 11 and type 6; ... |
102-116 | 4.42e-03 | ||
catalytic domain of tyrosine-protein phosphatase non-receptor type 11 and type 6; Tyrosine-protein phosphatase non-receptor type 11 (PTPN11) and type 6 (PTPN6) belong to the family of classical tyrosine-specific protein tyrosine phosphatases (PTPs). PTPs (EC 3.1.3.48) catalyze the dephosphorylation of phosphotyrosine peptides. PTPN11 and PTPN6, are also called SH2 domain-containing tyrosine phosphatase 2 (SHP2) and 1 (SHP1), respectively. They contain two tandem SH2 domains: a catalytic PTP domain, and a C-terminal tail with regulatory properties. Although structurally similar, they have different localization and different roles in signal transduction. PTPN11/SHP2 is expressed ubiquitously and plays a positive role in cell signaling, leading to cell activation, while PTPN6/SHP1 expression is restricted mainly to hematopoietic and epithelial cells and functions as a negative regulator of signaling events. Pssm-ID: 350392 [Multi-domain] Cd Length: 251 Bit Score: 35.90 E-value: 4.42e-03
|
||||||
Blast search parameters | ||||
|